Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

28 sept. 2004 12h59 HE | Source: Gardant Pharmaceuticals, Inc.

Bioaccelerate Portfolio Company Inncardio Inc. Enters into Licence and Co-development Agreement for INC 105 with the University of Strathclyde

NEW YORK, Sept. 28, 2004 (PRIMEZONE) -- Bioaccelerate Holdings, Inc. (OTCBB:BACL) a pharmaceutical development organization today announced that one of its portfolio companies, Inncardio Inc., a...
28 sept. 2004 12h01 HE | Source: Gardant Pharmaceuticals, Inc.

Bioaccelerate Portfolio Company Inncardio Inc. Enters into Licence and Co-development Agreement for INC 105 with the University of Strathclyde

NEW YORK, Sept. 28, 2004 (PRIMEZONE) -- Bioaccelerate Holdings, Inc. (OTCBB:BACL) a pharmaceutical development organization today announced that one of its portfolio companies, Inncardio Inc., a...
12 août 2004 12h16 HE | Source: Gardant Pharmaceuticals, Inc.

UPDATE: Bioaccelerate Portfolio Company Enhance Biotech to Merge with Privately-Held Ardent Pharmaceuticals -- the World Leader in the Discovery and Development of Delta Receptor Compounds

NEW YORK, Aug. 12, 2004 (PRIMEZONE) -- Bioaccelerate, Inc. , a pharmaceutical development organisation has today announced that one of its portfolio companies, Enhance Biotech Inc (Pink Sheets:EBOI),...
12 août 2004 10h53 HE | Source: Gardant Pharmaceuticals, Inc.

Bioaccelerate Portfolio Company Enhance Biotech to Merge with Privately-Held Ardent Pharmaceuticals -- the World Leader in the Discovery and Development of Delta Receptor Compounds

NEW YORK, Aug. 12, 2004 (PRIMEZONE) -- Bioaccelerate, Inc. , a pharmaceutical development organisation has today announced that one of its portfolio companies, Enhance Biotech Inc (Pink Sheets:EBOI),...

Page précédente